IP Library Granted Patent US 9,994,860
Granted Patent B2
US 9,994,860 · App. 14/822,105 · Granted Jun 12, 2018

Regulating alkaloids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,994,860
App. No.
14/822,105
Granted
Jun 12, 2018
Kind
B2
Abstract

MPO1 and MPO2 can be regulated for either decreasing or increasing alkaloid levels in plants, in particular in Nicotiana plants. In particular, suppressing or overexpressing one or more of MPO1 and MPO2 may be used to decrease or increase nicotine and nicotinic alkaloid levels in tobacco plants. Suppression or overexpression of one or more of MPO1 and MPO2 may be used in combination with modification of expression of other genes encoding enzymes on the nicotinic alkaloid biosynthetic pathway such as A622, NBB1, PMT, and QPT.

Claims (31)

1. A method of producing an N-methylputrescine oxidase (MPO) enzyme, comprising:

(a) introducing into a host cell a heterologous nucleic acid construct comprising a nucleotide sequence selected from the group consisting of:

(i) the nucleotide sequence set forth in SEQ ID NO: 3;

(ii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4; and

(iii) any combination of (i)-(ii); and

(b) growing said cell under conditions such that N-methylputrescine oxidase-2 (MPO2) is produced.

2. The method of claim 1 , wherein said host cell is selected from the group consisting of bacteria, yeast, filamentous fungi, algae, green plants, insect, and mammalian cells.

3. A method for increasing nicotine in a Nicotiana plant, comprising

(a) introducing into the plant a vector comprising a nucleotide sequence selected from the group consisting of:

(i) the nucleotide sequence set forth in SEQ ID NO: 3;

(ii) a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4; and

(iii) any combination of (i)-(ii); and

(b) growing the plant under conditions which allow for the expression of N-methylputrescine oxidase-2 (MPO2) from the nucleotide sequence;

wherein expression of the MPO2 results in the plant having an increased nicotine content relative to a control plant.

4. The method of claim 3 , further comprising overexpressing within the plant at least one of quinolate phosphoribosyl transferase (QPT), putrescine N-methyltransferase (PMT), A622, and NBB1.

5. An increased nicotine Nicotiana plant produced by the method of claim 3 , wherein the plant comprises the vector.

6. An increased nicotine product produced from the plant of claim 5 , wherein the product has an increased nicotine content as compared to a similar product produced from a control Nicotiana plant.

7. The product of claim 6 , wherein said product is an increased nicotine tobacco product selected from the group consisting of a cigarette, cigar, pipe tobacco, snus, snuff, and chewing tobacco.

8. A method for increasing nicotine and yield in a Nicotiana plant, comprising:

(a) crossing an increased nicotine Nicotiana plant of claim 5 with a high yielding Nicotiana plant; and

(b) selecting a progeny plant with increased nicotine and high yield.

9. A method for increasing the ratio of nicotine to total alkaloids in a tobacco plant, comprising:

(a) introducing into the plant a nucleic acid construct comprising:

(i) an expression cassette comprising at least one nucleotide sequence selected from the group consisting of the nucleotide sequence set forth in SEQ ID NO: 3, and a nucleotide sequence that encodes a polypeptide having the amino acid sequence set forth in SEQ ID NO: 4;

(ii) a putrescine N-methyltransferase (PMT) expression cassette; and

(iii) a quinolate phosphoribosyl transferase (QPT) suppression cassette; and

(b) growing the plant under conditions which allow for overexpression of MPO2, overexpression of PMT, and suppression of QPT,

wherein overexpression of MPO2, overexpression of PMT, and suppression of QPT results in the plant having an increased ratio of nicotine to total alkaloids in the plant relative to a non-transformed control plant.

10. A plant produced by the method of claim 9 , wherein the plant comprises the nucleic acid construct.

11. A product with an increased nicotine to total alkaloids ratio produced from the plant of claim 10 , wherein the product has an increased nicotine to total alkaloids ratio as compared to a similar product produced from a control plant.

12. The product of claim 11 , wherein said product is selected from the group consisting of a cigarette, cigar, pipe tobacco, snus, snuff, and chewing tobacco.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NARA INSTITUTE OF SCIENCE AND TECHNOLOGY
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055657/0765 →